The quality of care can be improved by the development and implementation of evidence-
based treatment guidelines. Different national guidelines for chronic obstructive pulmonary …

Inhaled corticosteroids are widely used in chronic obstructive pulmonary disease (COPD)
and, in combination with long-acting β 2 agonists, reduce exacerbations and improve lung …

Background Real-world prescription pathways leading to triple therapy (TT)(inhaled
corticosteroid [ICS] plus long-acting β2-agonist bronchodilator [LABA] plus long-acting …

According to the current clinical practice guidelines for chronic obstructive pulmonary
disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β 2 agonist …

Rationale: The efficacy of intensified combination therapy with inhaled corticosteroids (ICS)
and long-acting β2-agonists (LABA) at the onset of upper respiratory tract infection (URTI) …

Background An association between systemic corticosteroids and tuberculosis (TB) is
reported in the literature. Here within, we conducted a systematic review and meta-analysis …

Background Limited information is available regarding medication use in COPD patients
from Latin America. This study evaluated the type of medication used and the adherence to …

Purpose This study aimed to describe the real-world treatment of German incident COPD
patients, compare that treatment with clinical guidelines, and provide insight into disease …

International guidance on chronic obstructive pulmonary disease (COPD) management
recommends the use of inhaled corticosteroids (ICS) in those patients at increased …

Few studies have directly compared the incidence of pneumonia in patients on common
chronic obstructive pulmonary disease (COPD) treatments such as long-acting muscarinic …